<abstract xmlns="http://www.w3.org/1999/xhtml"><p>The novel coronavirus disease first appeared in Wuhan (China) is an infectious disease spreading throughout the world, causing life-threatening conditions in vulnerable or even healthy individuals. The great impact of this virus on healthcare urges physicians to investigate all aspects of the disease in order to overcome its complications. A particularly investigated aspect of the SARS-CoV-2 infection is represented by the coagulation disorders among infected and critically ill patients. Several studies observed modified blood coagulation parameters such as D-dimers, fibrinogen, and coagulation times. Moreover, the severe thrombotic complications, mainly pulmonary embolism, could be responsible for the high mortality and poorer outcomes of COVID-19 infected patients. The aim of this article is to present the current knowledge related to thrombosis predisposition in patients infected with the new coronavirus.</p></abstract>

The novel coronavirus disease first appeared in Wuhan (China) is an infectious disease spreading throughout the world, causing life-threatening conditions in vulnerable or even healthy individuals. The great impact of this virus on healthcare urges physicians to investigate all aspects of the disease in order to overcome its complications. A particularly investigated aspect of the SARS-CoV-2 infection is represented by the coagulation disorders among infected and critically ill patients. Several studies observed modified blood coagulation parameters such as D-dimers, fibrinogen, and coagulation times. Moreover, the severe thrombotic complications, mainly pulmonary embolism, could be responsible for the high mortality and poorer outcomes of COVID-19 infected patients. The aim of this article is to present the current knowledge related to thrombosis predisposition in patients infected with the new coronavirus.

COVID-19 and Thrombosis Predisposition

Journal of Interdisciplinary Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"COVID-19 and Thrombosis Predisposition"}

The novel coronavirus disease first appeared in Wuhan (China) is an infectious disease spreading throughout the world, causing life-threatening conditions in...

COVID-19 and Thrombosis Predisposition

Publicado en línea: 19 oct 2020

Páginas: 86 - 90

Recibido: 02 ago 2020

Aceptado: 04 sept 2020

DOI: https://doi.org/10.2478/jim-2020-0023

Palabras clave
COVID-19, thrombosis, coagulation disorders

© 2020 Renata Gerculy et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

COVID-19 and Thrombosis Predisposition

Publicado en línea: 19 oct 2020

Páginas: 86 - 90

Recibido: 02 ago 2020

Aceptado: 04 sept 2020

DOI: https://doi.org/10.2478/jim-2020-0023

Palabras claveCOVID-19, thrombosis, coagulation disorders

© 2020 Renata Gerculy et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Palabras clave
COVID-19, thrombosis, coagulation disorders